Document:

Exhibit

10.27

 

EMPLOYMENT AGREEMENT

 

THIS EMPLOYMENT AGREEMENT (this “Agreement”), dated

January 24, 2003, is made by and between NANOGEN, INC., a Delaware corporation

(hereinafter the “Company”), and GRAHAM LIDGARD (hereinafter “Executive”).

 

WHEREAS, the Company and Executive wish to set forth

in this Agreement the terms and conditions under which Executive will be

employed by the Company; and

 

WHEREAS, the Company wishes to be assured that

Executive will be available to the Company for an additional three (3) years

after January 24, 2003.

 

NOW, THEREFORE, the Company and Executive, in

consideration of the mutual promises set forth herein, agree as follows:

 

ARTICLE I.

 

TERM OF AGREEMENT

 

A.            Commencement

Date.  The terms of this Agreement

shall govern Executive’s employment with the Company from January 24, 2003

(“Commencement Date”) and this Agreement shall expire after a period of three

(3) years from the Commencement Date, unless terminated earlier pursuant to

Article 6.

 

B.            Renewal.  The term of this Agreement shall be

automatically renewed for successive, additional three (3) year terms unless

either party delivers written notice to the other at least ninety (90) days

prior to the expiration date of this Agreement of an intention to terminate

this Agreement or to renew it for a term of less than three (3) years but not

less than (1) year.  If the term of this

Agreement is renewed for a term of less than three (3) years, then thereafter

the term of this Agreement shall be automatically renewed for successive,

additional identical terms unless either party delivers a written notice to the

other at least ninety (90) days prior to a termination date of this Agreement

of an intention to terminate this Agreement or to renew it for a different term

of not less than one (1) year.  Any

renewal bonus will be negotiated as mutually agreed to at the time of any

renewal of this Agreement.

 

If this Agreement is not renewed at the end of any

term hereof by the Company for any reason except death, disability or

retirement of Executive, notwithstanding anything herein elsewhere contained,

Executive shall be paid his salary, as provided for in Section 3.A hereof, and

receive the other benefits applicable under Article 4 hereof, for an

additional six (6) months after the termination date hereof.

ARTICLE II.

 

EMPLOYMENT DUTIES

 

A.            Title/Responsibilities.  Executive hereby accepts employment with the

Company pursuant to the terms and conditions hereof.  Executive agrees to serve the Company in the position of Senior

Vice President, Research & Development. 

Executive shall have the powers and duties commensurate with such

position, including but not limited to, hiring personnel

 

1

 

necessary (in the judgment of the Board of Directors) to carry out the

responsibilities for such position.

 

B.            Full

Time Attention.  Executive shall

devote his best efforts and his full business time and attention to the

performance of the services customarily incident to such office and to such

other services as the Board may reasonably request.

 

C.            Other

Activities.  Except upon the prior

written consent of the Board of Directors, Executive shall not during the

period of employment engage, directly or indirectly, in any other business

activity (whether or not pursued for pecuniary advantage) that is or may be

competitive with, or that might place him in a competing position to that of

the Company or any other corporation or entity that directly or indirectly

controls, is controlled by, or is under common control with the Company (an

“Affiliated Company”), provided that Executive may own less than two percent of

the outstanding securities of any such publicly traded competing corporation.

 

ARTICLE III.

 

COMPENSATION

 

A.            Base

Salary.  Executive shall receive a

Base Salary at an annual rate of two hundred ten thousand dollars ($210,000),

payable in accordance with the Company’s customary payroll practices.  The Company’s Board of Directors shall

provide Executive with annual performance reviews, and, thereafter, Executive

shall be entitled to such Base Salary as the Board of Directors may from time

to time establish in its sole discretion.

 

B.            Achievement

Bonus.  The Company shall pay

Executive an Achievement Bonus of up to 50% of Executive’s Base Salary annually

based upon achievement by the Company of its corporate goals as established and

determined by the Board of Directors annually and for other achievements by the

Company or the Executive during the year as approved by the Compensation

Committee.  The Board of Directors or

Compensation Committee, as applicable, shall, in their respective sole

discretion, determine whether such corporate or other goals have been attained

or other achievements have occurred.

 

C.            Transaction

Bonus.  In addition, in the event of

a transaction involving a Change in Control, in a transaction approved by the

Company’s Board of Directors, which transaction results in the receipt by the

Company’s stockholders of consideration with a value representing, in the sole

judgment of the Board of Directors, a significant premium over the average of

the closing prices per share of the Company’s common stock as quoted on the

Nasdaq National Market for 20 trading days ending one day prior to the public

announcement of such transaction (a “Change in Control Transaction”), Executive

shall be paid a Transaction Bonus at the closing of such a transaction in the

amount equal to one (1) times 50% of Executive’s Base Salary in effect

immediately preceding the closing of such a transaction.  Executive shall also be paid said

Transaction Bonus if the Company enters into a transaction approved by the

Board of Directors which is not a Change in Control Transaction, but which,

nonetheless, involves a significant change in the ownership of the Company or

the composition of the Board of Directors of the Company, and which results in

significant additional value for the Company’s stockholders, as determined by

the Board of Directors in its sole discretion and as specifically designated a

significant event by the Board of Directors (a “Significant Event”).  In the event

 

2

 

Executive receives a Transaction Bonus, no Achievement Bonus will be

paid to Executive in the year in which such Transaction Bonus is paid.

 

If the Company enters into a transaction which is a

Change in Control Transaction, then all of the Executive’s stock options

received before the date of the transaction shall become exercisable in full

and all of the shares of the common stock of the Company awarded to Executive

under the Company’s 1997 Stock Incentive Plan (or any subsequent plan) shall

become fully vested.  If the Company

enters into a transaction which is not a Change in Control Transaction but

which is a Significant Event, then the Board of Directors may, in its sole

discretion, determine that all, or a portion, of the Executive’s stock options

received before the effective date of the transaction shall become exercisable

in full and all, or a portion, of the shares of the common stock of the Company

awarded to Executive under the Company’s 1997 Stock Incentive Plan (or any

subsequent plan) shall become fully vested.

 

D.            Withholdings.  All compensation and benefits to Executive

hereunder shall be subject to all federal, state, local and other withholdings

and similar taxes and payments required by applicable law.

 

ARTICLE IV.

 

EXPENSE ALLOWANCES AND

FRINGE BENEFITS

 

A.            Vacation.  Executive shall be entitled to three (3)

weeks, plus one (1) additional day for each completed year of employment with

the Company, of annual paid vacation during the term of this Agreement.

 

B.            Benefits.  During the term of this Agreement, the

Company shall also provide Executive with the usual health insurance benefits

and life insurance it generally provides to its other senior management

employees.  As Executive becomes

eligible in accordance with criteria to be adopted by the Company, the Company

shall provide Executive with the right to participate in and to receive

benefits from accident, disability, medical, pension, bonus, stock,

profit-sharing and savings plans and similar benefits made available generally

to employees of the Company as such plans and benefits may be adopted by the

Company, provided that Executive shall during the term of this Agreement be entitled

to receive at a minimum standard medical and dental benefits similar to those

typically afforded to a Senior Vice President, Research & Development in

similar sized biotech­nology companies. 

The amount and extent of benefits to which Executive is entitled shall

be governed by the specific benefit plan as it may be amended from time to

time.

 

C.            Business

Expense Reimbursement.  During the

term of this Agreement, Executive shall be entitled to receive proper

reimbursement for all reasonable out-of-pocket expenses incurred by him (in

accordance with the policies and procedures established by the Company for its

senior executive officers) in performing services hereunder, provided Executive

properly accounts therefor.

 

3

 

ARTICLE V.

 

CONFIDENTIALITY

 

A.            Proprietary

Information.  Executive represents

and warrants that he has executed and delivered to the Company the Company’s

standard Proprietary Information, Inventions and Dispute Resolution Agreement

in form acceptable to the Company’s counsel.

 

B.            Return

of Property.  All documents,

records, apparatus, equipment and other physical property which is furnished to

or obtained by Executive in the course of his employment with the Company shall

be and remain the sole property of the Company.  Executive agrees that, upon the termination of his employment, he

shall return all such property (whether or not it pertains to Proprietary

Information as defined in the Proprietary Information, Inventions and Dispute

Resolution Agreement), and agrees not to make or retain copies, reproductions

or summaries of any such property.

 

ARTICLE VI.

 

TERMINATION

 

A.            By

Death.  The period of employment

shall terminate automatically upon the death of Executive.  In such event, the Company shall pay to

Executive’s beneficiaries or his estate, as the case may be, any accrued Base

Salary, any bonus compensation to the extent earned, any vested deferred

compensation (other than pension plan or profit-sharing plan benefits which

will be paid in accordance with the applicable plan), any benefits under any

plans of the Company in which Executive is a participant to the full extent of

Executive’s rights under such plans, any accrued vacation pay and any

appropriate business expenses incurred by Executive in connection with his

duties hereunder, all to the date of termination (collectively “Accrued

Compensation”), but no other compensation or reimbursement of any kind,

including, without limitation, severance compensation, and thereafter, the Company’s

obligations hereunder shall terminate.

 

B.            By

Disability.  If Executive is

prevented from properly performing his duties hereunder by reason of any

physical or mental incapacity for a period of more than 90 days in the

aggregate in any 365-day period, then, to the extent permitted by law, the

Company may terminate the employment on the 90th day of such incapacity.  In such event, the Company shall pay to

Executive all Accrued Compensation, and shall continue to pay to Executive the

Base Salary until such time (but not more than 90 days following termination),

as Executive shall become entitled to receive disability insurance payments

under the disability insurance policy maintained by the Company, which

disability policy shall provide for full payment of Executive’s Base Salary

during the period of disability, but no other compensation or reimbursement of

any kind, including without limitation, severance compensation, and thereafter

the Company’s obligations hereunder shall terminate.  Nothing in this Section shall affect Executive’s rights under any

disability plan in which he is a participant.

 

4

 

C.            By

Company for Cause.  The Company may

terminate Executive’s employment for Cause (as defined below) without liability

at any time with or without advance notice to Executive.  The Company shall pay Executive all Accrued

Compensation, but no other compen­sation or reimbursement of any kind,

including without limitation, severance compensation, and thereafter the

Company’s obligations hereunder shall terminate.  Termination shall be for “Cause” in the event of the occurrence

of any of the following:  (a) any

intentional action or intentional failure to act by Executive which was

performed in bad faith and to the material detriment of the Company;

(b) Executive intentionally refuses or intentionally fails to act in

accordance with any lawful and proper direction or order of the Board;

(c) gross negligence by Executive in carrying out the duties of employment;

or (d) Executive is convicted of a felony crime involving moral turpitude,

provided that in the event that any of the foregoing events is capable of being

cured, the Company shall provide written notice to Executive describing the

nature of such event and Executive shall thereafter have five (5) business days

to cure such event.

 

D.            At

Will.  At any time, the Company may

terminate Executive’s employment without liability other than as set forth

below, for any reason not specified in Section 6.C above, by giving thirty

(30) days advance written notice to Executive. 

If the Company elects to terminate Executive pursuant to this

Section 6.D prior to a Change in Control, the Company shall pay to

Executive all Accrued Compensation and shall continue to pay to Executive as

provided herein Executive’s Salary for six (6) months from the date of such

termination as severance compensation. 

If the Company or its successor elects to terminate Executive pursuant

to this Section after a Change in Control, the Company (or its successor) shall

continue to pay to Executive as provided herein Executive’s Salary for six (6)

months from the date of such termination as severance compensation. Upon

payment of the severance benefits described herein, all obligations of the

Company (or its successor) shall terminate.

 

During the period when such severance compensation is

being paid to Executive, Executive shall not (i) engage, directly or

indirectly, in any other business activity that is competitive with, or that

places him in a competing position to that of the Company or any Affiliated

Company (provided that Executive may own less than two percent (2%) of the

outstanding securities of any publicly traded corporation), or (ii) hire,

solicit, or attempt to hire on behalf of himself or any other party any

employee or exclusive consultant of the Company.  If the Company terminates this Agreement or the employment of

Executive with the Company other than pursuant to Section 6.A, 6.B or 6.C,

then this Section 6.D shall apply.

 

E.             Constructive

Termination.  In the event that the

Company shall materially reduce the powers and duties of employment of

Executive resulting in a material decrease in the responsibilities of Executive

which are inconsistent with Executive acting as Senior Vice President, Research

& Development of the Company, such action shall be deemed to be a

termination of employment of Executive without cause pursuant to

Section 6.D.  In the event of a

Change in Control of the Company in which the Company shall become a division

or subsidiary of a larger organization, references to the Senior Vice

President, Research & Development of the Company shall be deemed to mean

the Senior Vice President, Research & Development of such division or

subsidiary for purposes of this Section 6.E.

 

F.             Change

in Control.  For purposes of this

Agreement, a “Change in Control” shall have occurred if at any time during the

term of Executive’s employment hereunder, any of the following events shall

occur:

 

5

 

1.             The

consummation of a merger or consolidation of the Company with or into another

entity or any other corporate reorganization, if more than 50% of the combined

voting power of the continuing or surviving entity’s securities outstanding

immediately after such merger, consolidation or other reorganization is owned

by persons who were not stockholders of the Company immediately prior to such

merger, consolidation or other reorganization;

 

2.             A

change in the composition of the Board, as a result of which fewer than

one-half of the incumbent directors are directors who either (1) had been

directors of the Company 24 months prior to such change; or (2) were elected,

or nominated for election, to the Board with the affirmative votes of at least

a majority of the directors who had been directors of the Company 24 months

prior to such change and who were still in office at the time of the election

or nomination; or

 

3.             Any

“person” (as such term is used in Section 13(d) and Section 14 of the Exchange

Act) by the acquisition of securities is or becomes the beneficial owner,

directly or indirectly, of securities of the Company representing 50% or more

of the combined voting power of the Company’s then outstanding securities

ordinarily (and apart from rights accruing under special circumstances) having

the right to vote at elections of directors (the “Base Capital Stock”) except

that any change in the relative beneficial ownership of the Company’s

securities resulting solely from a reduction in the aggregate number of

outstanding shares of Base Capital Stock , and any decrease thereafter in such

person’s ownership of securities shall be disregarded until such person

increases in any manner, directly or indirectly, such person’s beneficial

ownership of any securities of the Company. Thus, for example, any person who

owns less than 50% of the Company’s outstanding shares, shall cause a Change in

Control to occur as of any subsequent date if such person then acquires an

additional interest in the Company which, when added to the person’s previous

holdings, causes the person to hold more than 50% of the Company’s outstanding

shares.

 

The term “Change in Control” shall not include a

transaction, the sole purpose of which is to change the state of the Company’s

incorporation.

 

ARTICLE VII.

 

GENERAL PROVISIONS

 

A.            Governing

Law.  The validity, interpretation,

construc­tion and performance of this Agreement and the rights of the parties

thereunder shall be interpreted and enforced under California law without

reference to principles of conflicts of laws. 

The parties expressly agree that inasmuch as the Company’s headquarters

and principal place of business are located in California, it is appropriate

that California law govern this Agreement.

 

B.            Assignment;

Successors; Binding Agreement.

 

1.  Executive

may not assign, pledge or encumber his interest in this Agreement or any part

thereof.

 

6

 

2.  The Company

will require any successor (whether direct or indirect, by purchase, merger,

consolidation or otherwise) to all or substantially all of the business and/or

assets of the Company, operation of law or by agreement in form and substance

reasonably satisfactory to Executive, to assume and agree to perform this

Agreement in the same manner and to the same extent that the Company would be

required to perform it if no such succession had taken place.

 

3.  This

Agreement shall inure to the benefit of and be enforceable by Executive’s

personal or legal representatives, executors, administrators, successors,

heirs, distributee, devisees and legatees. 

If Executive should die while any amount is at such time payable to him

hereunder, all such amounts, unless otherwise provided herein, shall be paid in

accordance with the terms of this Agreement to Executive’s devisee, legates or

other designee or, if there be no such designee, to his estate.

 

C.            No

Waiver of Breach.  The waiver by any

party of the breach of any provision of this Agreement shall not be deemed to

be a waiver of any subsequent breach.

 

D.            Notice.  For the purposes of this Agreement, notices

and all other communications provided for in this Agreement shall be in writing

and shall be deemed to have been duly given when delivered or mailed by

certified or registered mail, return receipt requested, postage prepaid,

addressed to the respective addresses set forth below or to such other address

as either party may have furnished to the other in writing in accordance

herewith, except that notice of change of address shall be effective only upon

receipt.

 

	

  To the Company:

  	

   

  	

  Nanogen, Inc.

  
	

   

  	

   

  	

  10398 Pacific Center

  Court

  
	

   

  	

   

  	

  San Diego, CA 92121

  
	

   

  	

   

  	

  Attn:  Chief Executive Officer

  
	

   

  	

   

  	

   

  
	

  To Executive:

  	

   

  	

  Dr. Graham Lidgard

  
	

   

  	

   

  	

  c/o Nanogen, Inc.

  
	

   

  	

   

  	

  10398 Pacific Center

  Court

  
	

   

  	

   

  	

  San Diego, CA 92121

  

 

E.             Modification;

Waiver; Entire Agreement.  No

provisions of this Agreement may be modified, waived or discharged unless such

waiver, modification or discharge is agreed to in writing signed by Executive

and such officer as may be specifically designated by the Board of the

Company.  No waiver by either party

hereto at any time of any breach by the other party of, or compliance with, any

condition or provision of this Agreement to be performed by such other party

shall be deemed a waiver of similar or dissimilar provisions or conditions at

the same or any prior or subsequent time. 

No agreements or representations, oral or otherwise, express or implied,

with respect to the subject matter hereof have been made by either party which

are not expressly set forth in this Agreement.

 

F.             Validity.  The invalidity or unenforceability of any

provision of this Agreement shall not affect the validity or enforceability of

any other provision of this Agreement, which shall remain in full force and

effect.

 

7

 

G.            Controlling

Document.  This Agreement supersedes

any and all prior employment agreements or consulting agreements between the

Company and Executive, but does not supersede any other agreements between

Company and Executive, including but not limited to, the Nanogen Inc.

Restricted Stock Purchase Agreement, any stock option agreements or common

stock purchase agreements entered into pursuant to the Company’s 1997 Stock

Incentive Plan, and the Nanogen Employees’ Handbook and Policies, except as

expressly provided herein.  In case of

conflict between any of the terms and conditions of this Agreement and the

documents herein referred to, the terms and conditions of this Agreement shall

control.

 

H.            Executive

Acknowledgment.  Executive

acknowledges (a) that he has consulted with or has had the opportunity to

consult with independent counsel of his own choice concerning this Agreement,

and has been advised to do so by the Company, and (b) that he has read and

understands the Agreement, is fully aware of its legal effect, and has entered

into it freely based on his own judgment.

 

I.              Remedies.

 

1.             Injunctive

Relief.  The parties agree that the

services to be rendered by Executive hereunder are of a unique nature and that

in the event of any breach or threatened breach of any of the covenants

contained herein, the damage or imminent damage to the value and the goodwill

of the Company’s business will be irreparable and extremely difficult to

estimate, making any remedy at law or in damages inadequate.  Accordingly, the parties agree that the

Company shall be entitled to injunctive relief against Executive in the event

of any breach or threatened breach of any such provisions by Executive, in

addition to any other relief (including damages) available to the Company under

this Agreement or under law.

 

2.             Exclusive.  Both parties agree that the remedy specified

in Section 7.I.1 above is not exclusive of any other remedy for the breach

by Executive of the terms hereof.

 

J.             Counterparts.  This Agreement may be executed in one or

more counterparts, all of which taken together shall constitute one and the

same Agreement.

 

Executed by the parties as of the day and year first

above written.

 

	

   

  	

   

  	

  NANOGEN, INC.

  
	

   

  	

   

  	

   

  
	

   

  	

   

  	

   

  
	

   

  	

   

  	

  By:

  	

  /s/ HOWARD C. BIRNDORF

  	

   

  
	

   

  	

   

  	

   

  	

  Howard

  C. Birndorf

  
	

   

  	

   

  	

   

  	

  Executive

  Chairman

  
	

   

  	

   

  	

   

  
	

   

  	

   

  	

   

  
	

   

  	

   

  	

  EXECUTIVE:

  
	

   

  	

   

  	

   

  
	

   

  	

   

  	

   

  
	

   

  	

   

  	

  By:

  	

  /s/ GRAHAM LIDGARD

  	

   

  
	

   

  	

   

  	

   

  	

  Graham

  Lidgard

  

 

8Exhibit
No. 10.30

 

INDEMNIFICATION AGREEMENT

 

THIS INDEMNIFICATION
AGREEMENT is made effective as of the 1st day of December, 2002 (the
“Agreement”), by and between NANOGEN, INC., a Delaware corporation (the
“Company”) and BRUCE A. HUEBNER (the “Indemnitee”) with reference to the
following facts:

 

WHEREAS, the Company
desires the benefits of having Indemnitee serve as an officer and/or director
secure in the knowledge that any expenses, liability and/or losses incurred by
him in his good faith service to the Company will be borne by the Company or
its successors and assigns; and

 

WHEREAS, Indemnitee is
willing to serve in his position with the Company only on the condition that he
be indemnified for such expenses, liability and/or losses; and

 

WHEREAS, the Company and
Indemnitee recognize the increasing difficulty in obtaining liability insurance
for directors, officers and agents of a corporation at reasonable cost; and

 

WHEREAS, the Company and
Indemnitee recognize that there has been an increase in litigation against
corporate directors, officers and agents; and

 

WHEREAS, the Company’s
Restated Certificate of Incorporation allows and requires the Company to
indemnify its directors, officers and agents to the maximum extent permitted
under Delaware law:

 

NOW, THEREFORE, the
parties hereby agree as follows:

 

1.             Definitions.  
For purposes of this Agreement:

 

1.1           “Agent” shall mean any person who
(a) is or was a director, officer, employee or agent of the Company or a
subsidiary of the Company whether serving in such capacity or as a director,
officer, employee, agent, fiduciary or other official of another corporation,
joint venture, trust or other enterprise at the request of, for the convenience
of, or to represent the interests of the Company or a subsidiary of the Company
or (b) was a director, officer, employee or agent of Nanogen, Inc., a
California corporation and the predecessor by merger to the Company (the
“Predecessor Corporation”), whether serving in such capacity or as a director,
officer, employee, agent, fiduciary or other official of another corporation,
joint venture, trust or other enterprise at the request of, for the convenience
of, or to represent the interests of such Predecessor Corporation.

 

1.2           “Change of Control” shall mean the
occurrence of any of the following events after the date of this Agreement:

 

 

(a)           A change in the composition of the
board of directors of the Company (the “Board”), as a result of which fewer
than two-thirds of the incumbent directors are directors who either (a) had
been directors of the Company 24 months prior to such change or (b) were
elected, or nominated for election, to the Board with the affirmative votes of
at least a majority of the directors who had been directors of the Company 24
months prior to such change and who were still in office at the time of the
election or nomination; or

 

(b)           Any “person” (as such term is used in
sections 13(d) and 14(d) of the Securities Exchange Act of 1934 (the “Exchange
Act”), as amended) through the acquisition or aggregation of securities is or
becomes the beneficial owner, directly or indirectly, of securities of the
Company representing 20 percent or more of the combined voting power of the
Company’s then outstanding securities ordinarily (and apart from rights accruing
under special circumstances) having the right to vote at elections of directors
(the “Capital Stock”); provided, however, that any change in ownership
of the Company’s securities by any person resulting solely from a reduction in
the aggregate number of outstanding shares of Capital Stock, and any decrease
thereafter in such person’s ownership of securities, shall be disregarded until
such person increases in any manner, directly or indirectly, such person’s
beneficial ownership of any securities of the Company.

 

1.3           “Disinterested Director” shall mean a
director of the Company who is not and was not a party to the Proceeding in
respect of which indemnification is being sought by Indemnitee.

 

1.4           “Expenses” shall be broadly construed
and shall include, without limi­ta­tion, (a) all direct and indirect costs
incurred, paid or accrued, (b) all attorneys’ fees, retainers, court
costs, transcripts, fees of experts, witness fees, travel expenses, food and
lodging expenses while traveling, duplicating costs, printing and binding
costs, telephone charges, postage, delivery service, freight or other
transportation fees and expenses, (c) all other disbursements and out-of-pocket
expenses, (d) amounts paid in settlement, to the extent not prohibited by
Delaware Law, and (e) reasonable compensation for time spent by Indemnitee
for which he is otherwise not compensated by the Company or any third party,
actually and reasonably incurred in connection with or arising out of a
Proceeding, including a Proceeding by Indemnitee to establish or enforce a
right to indemnification under this Agreement, applicable law or otherwise.

 

1.5           “Independent Counsel” shall mean a
law firm or a member of a law firm that neither is presently nor in the past
five years has been retained to represent: 
(a) the Company, an affiliate of the Company or Indemnitee in any
matter material to either party or (b) any other party to the Proceeding
giving rise to a claim for indemnification hereunder.  Notwithstanding the foregoing, the term “Independent Counsel”
shall not include any person who, under the applicable standards of
professional conduct then prevailing, would have a conflict of interest in
representing either the Company or Indemnitee in an action to determine
Indemnitee’s right to indemnification under this Agreement.

 

1.6           “Liabilities” shall mean liabilities
of any type whatsoever, including, but not limited to, judgments or fines,
ERISA or other excise taxes and penalties, and amounts paid in settlement
(including all interest, assessments or other charges paid or payable in
connection with

 

2

 

any of the foregoing) actually and reasonably incurred by Indemnitee in
connection with a Proceeding.

 

1.7           “Delaware Law” means the Delaware
General Corporation Law, as amended and in effect from time to time, or any
successor or other statutes of Delaware having similar import and effect.

 

1.8           “Proceeding” shall mean any pending,
threatened or completed action, hearing, suit or any other proceeding, whether
civil, criminal, arbitrative, admini­strative, investigative or any alternative
dispute resolution mechanism, including without limitation any such Proceeding
brought by or in the right of the Company.

 

2.             Employment Rights and Duties.   Subject to any other obligations imposed on
either of the parties by contract or by law, and with the understanding that
this Agreement is not intended to confer employment rights on either party
which they did not possess on the date of its execution, Indemnitee agrees to
serve as a director or officer so long as he is duly appointed or elected and
qualified in accordance with the applicable provisions of the Restated
Certificate of Incorporation (the “Certificate”) and Bylaws (the “Bylaws”) of
the Company or any subsidiary of the Company and until such time as he resigns
or fails to stand for election or until his employment terminates.  Indemnitee may from time to time also
perform other services at the request, or for the convenience of, or otherwise
benefiting the Company.  Indemnitee may
at any time and for any reason resign or be removed from such position (subject
to any other contractual obligation or other obligation imposed by operation of
law), in which event the Company shall have no obligation under this Agreement
to continue Indemnitee in any such position.

 

2.1           Directors’ and Officers’ Insurance.

 

(a)           The Company hereby covenants and
agrees that, so long as Indemnitee shall continue to serve as a director or
officer of the Company and thereafter so long as Indemnitee shall be subject to
any possible Proceeding, the Company, subject to Section 2.1(c), shall maintain
directors’ and officers’ insurance in full force and effect.

 

(b)           In all policies of directors’ and
officers’ insurance, Indemnitee shall be named as an insured in such a manner
as to provide Indemnitee the same rights and benefits, subject to the same
limitations, as are accorded to the Company’s directors or officers most
favorably insured by such policy.

 

(c)           The Company shall have no obligation
to maintain directors’ and officers’ insurance if the Company determines in
good faith that such insurance is not reasonably available, the premium costs
for such insurance are disproportionate to the amount of coverage provided, or
the coverage provided by such insurance is limited by exclusions so as to
provide an insufficient benefit.

 

3.             Indemnification. 
The Company shall indemnify Indemnitee to the fullest extent authorized
or permitted by Delaware Law and the provisions of the Certificate and Bylaws
of the Company in effect on the date hereof, and as Delaware Law, the
Certificate and Bylaws may

 

3

 

from time to time be amended (but, in the case of any such amendment,
only to the extent such amendment permits the Company to provide broader
indemnification rights than Delaware Law, the Certificate and/or Bylaws
permitted the Company to provide before such amend­ment).  The right to indemnification conferred in
the Certificate shall be presumed to have been relied upon by Indemnitee in
serving or continuing to serve the Company as a director or officer and shall
be enforceable as a contract right. 
Without in any way diminishing the scope of the indemnification provided
by the Certificate and this Section 3, the Company shall indemnify
Indemnitee if and whenever he is or was a witness, party or is threatened to be
made a witness or a party to any Proceeding, by reason of the fact that he is
or was an Agent or by reason of anything done or not done, or alleged to have
been done or not done, by him in such capacity, against all Expenses and
Liabilities actually and reasonably incurred by Indemnitee or on his behalf in
connection with the investigation, defense, settlement or appeal of such
Proceeding.  In addition to, and not as
a limitation of, the foregoing, the rights of indemnification of Indemnitee
provided under this Agreement shall include those rights set forth in
Sections 4, 5 and 6 below.

 

4.             Payment of Expenses.

 

4.1           All Expenses incurred by or on behalf
of Indemnitee shall be advanced by the Company to Indemnitee within 20 days
after the receipt by the Company of a written request for such advance which
may be made from time to time, whether prior to or after final disposition of a
Proceeding (unless there has been a final determination by a court of competent
jurisdiction that Indemnitee is not entitled to be indemnified for such
Expenses).  Indemnitee’s entitlement to
advancement of Expenses shall include those incurred in connection with any Proceeding
by Indemnitee seeking a determination, an adjudication or an award in
arbitration pursuant to this Agreement. The requests shall reasonably evidence
the Expenses incurred by Indemnitee in connection therewith.  Indemnitee hereby undertakes to repay the
amounts advanced if it shall ultimately be determined that Indemnitee is not
entitled to be indemnified pursuant to the terms of this Agreement.

 

4.2           Notwithstanding any other provision
in this Agreement, to the extent that Indemnitee has been successful on the
merits or otherwise in defense of any Proceeding, Indemnitee shall be
indemnified against all Expenses actually and reasonably incurred by Indemnitee
in connection therewith.

 

5.             Procedure for Determination of Entitlement to
Indemnification.

 

5.1           Whenever Indemnitee believes that he
is entitled to indemnification pursuant to this Agreement, Indemnitee shall
submit a written request for indemni­fi­cation (the “Indemnification Request”)
to the Company to the attention of the President with a copy to the
Secretary.  This request shall include
documentation or information which is necessary for the determination of
entitlement to indemni­fi­cation and which is reasonably available to
Indemnitee. Determination of Indemnitee’s entitlement to indemnification shall
be made no later than 60 days after receipt of the Indemnification
Request.  The President or the Secretary
shall, promptly upon receipt of Indemnitee’s request for indemnification,
advise the Board in writing that Indemnitee has made such request for
indemnification.

 

4

 

5.2           The Indemnification Request shall set
forth Indemnitee’s selection of which of the following forums shall determine
whether Indemnitee is entitled to indemnification:

 

(1)           A majority vote of Directors who are
not parties to the action with respect to which indemnification is sought, even
though less than a quorum.

 

(2)           A written opinion of an Independent
Counsel (provided there are no such Directors as set forth in (1) above or if
such Directors as set forth in (1) above so direct).

 

(3)           A majority vote of the stockholders
at a meeting at which a quorum is present, with the shares owned by the person
to be indemnified not being entitled to vote thereon.

 

(4)           The court in which the Proceeding is
or was pending upon application by Indemnitee.

 

The Company agrees to
bear any and all costs and expenses incurred by Indemnitee or the Company in
connection with the determination of Indemnitee’s entitlement to
indemnification by any of the above forums.

 

6.             Presumptions and Effect of Certain Proceedings.  No initial finding by the Board, its
counsel, Independent Counsel, arbitrators or the stockholders shall be
effective to deprive Indemnitee of the protection of this indemnity, nor shall
a court or other forum to which Indemnitee may apply for enforcement of this
indemnity give any weight to any such adverse finding in deciding any issue
before it.  Upon making a request for
indemnification, Indemnitee shall be presumed to be entitled to indemnification
under this Agreement and the Company shall have the burden of proof to overcome
that presumption in reaching any contrary determination.  The termination of any Proceeding by
judgment, order, settlement, arbitration award or conviction, or upon a plea of
nolo
contendere or its equivalent, shall not, of itself,
(a) adversely affect the rights of Indemnitee to indemnification except as
indemnifi­cation may be expressly prohibited under this Agreement,
(b) create a presumption that Indemnitee did not act in good faith and in
a manner which he reasonably believed to be in or not opposed to the best
interests of the Company or (c) with respect to any criminal action or
proceeding, create a presumption that Indemnitee had reasonable cause to believe
that his conduct was unlawful.

 

7.             Remedies of Indemnitee in Cases of Determination Not
to Indemnify or to Advance Expenses.

 

7.1           In the event that (a) an initial
determination is made that Indemnitee is not entitled to indemnification,
(b) advances for Expenses are not made when and as required by this
Agreement, (c) payment has not been timely made following a determination
of entitlement to indemnification pursuant to this Agreement or
(d) Indemnitee otherwise seeks enforcement of this Agreement, Indemnitee
shall be entitled to a final adjudication in an appropriate court of the State
of Delaware of his entitlement to such indemnification or advance.  Alternatively, Indemnitee at his option may
seek an award in arbitration.  If the
parties are unable to agree on an arbitrator, the parties shall provide JAMS
Endispute (“JAMS”) with a statement of the nature of the dispute and the
desired qualifications of the arbitrator. 
JAMS will then provide a list of three

 

5

 

available arbitrators.  Each
party may strike one of the names on the list, and the remaining person will
serve as the arbitrator.  If both
parties strike the same person, JAMS will select the arbitrator from the other
two names.  The arbitration award shall
be made within 90 days following the demand for arbitration.  Except as set forth herein, the provisions
of Delaware law shall apply to any such arbitration.  The Company shall not oppose Indemnitee’s right to seek any such
adjudication or arbitration award. In any such proceeding or arbitration
Indemnitee shall be presumed to be entitled to indemnification under this
Agreement and the Company shall have the burden of proof to overcome that
presumption.

 

7.2           An initial determination, in whole or
in part, that Indemnitee is not entitled to indemnification shall create no
presumption in any judicial proceeding or arbitration that Indemnitee has not
met the applicable standard of conduct for, or is otherwise not entitled to,
indemnification.

 

7.3           If an initial determination is made
or deemed to have been made pursuant to the terms of this Agreement that
Indemnitee is entitled to indemnifi­cation, the Company shall be bound by such
determination in the absence of (a) a misrepre­sentation of a material
fact by Indemnitee in the request for indemnification or (b) a specific
finding (which has become final) by a court of competent jurisdiction that all
or any part of such indemnification is expressly prohibited by law.

 

7.4           The Company and Indemnitee agree
herein that a monetary remedy for breach of this Agreement, at some later date,
will be inadequate, impracticable and difficult of proof, and further agree
that such breach would cause Indemnitee irreparable harm.  Accordingly, the Company and Indemnitee
agree that Indemnitee shall be entitled to temporary and permanent injunctive
relief to enforce this Agree­ment without the necessity of proving actual
damages or irreparable harm.  The
Company and Indemnitee further agree that Indemnitee shall be entitled to such
injunctive relief, including temporary restraining orders, preliminary
injunctions and permanent injunctions, without the necessity of posting bond or
other undertaking in connection therewith. 
Any such requirement of bond or undertaking is hereby waived by the
Company, and the Company acknowledges that in the absence of such a waiver, a
bond or undertaking may be required by the court.

 

7.5           The Company shall be precluded from
asserting that the procedures and presumptions of this Agreement are not valid,
binding and enforceable.  The Company
shall stipulate in any such court or before any such arbitrator that the
Company is bound by all the provisions of this Agreement and is precluded from
making any assertion to the contrary.

 

7.6           Expenses incurred by Indemnitee in
connection with his request for indemnification under, seeking enforcement of
or to recover damages for breach of this Agreement shall be borne and advanced
by the Company.

 

8.             Other Rights to Indemnification.  Indemnitee’s rights of indemnifi­cation and
advancement of expenses provided by this Agreement shall not be deemed
exclusive of any other rights to which Indemnitee may now or in the future be
entitled under applicable law, the

 

6

 

Certificate, the Bylaws, an employment agree­ment, a vote of
stockholders or Disinterested Directors, insurance or other financial
arrangements or otherwise.

 

9.             Limitations on Indemnification.  No indemnification pursuant to
Section 3 shall be paid by the Company nor shall Expenses be advanced
pursuant to Section 3:

 

9.1           Insurance.  To the extent that Indemnitee is reimbursed
pursuant to such insurance as may exist for Indemnitee’s benefit.  Notwithstanding the avail­ability of such
insurance, Indemnitee also may claim indemnification from the Company pursuant
to this Agreement by assigning to the Company any claims under such insurance
to the extent Indemnitee is paid by the Company.  Indemnitee shall reimburse the Company for any sums he receives
as indemnification from other sources to the extent of any amount paid to him
for that purpose by the Company;

 

9.2           Section 16(b).  On account and to the extent of any wholly
or partially successful claim against Indemnitee for an accounting of profits
made from the purchase or sale by Indemnitee of securities of the Company
pursuant to the provisions of Section 16(b) or the Securities Exchange Act of
1934, as amended, and amendments thereto or similar provisions of any federal,
state or local statutory law; or

 

9.3           Indemnitee’s Proceedings.  Except as otherwise provided in this
Agreement, in connection with all or any part of a Proceeding which is
initiated or maintained by or on behalf of Indemnitee, or any Proceeding by
Indemnitee against the Company or its directors, officers, employees or other
agents, unless (a) such indemnification is expressly required to be made
by Delaware Law, (b) the Proceeding was authorized by a majority of the
Disinterested Directors, (c) there has been a Change of Control or (d) such
indemnification is provided by the Company, in its sole discretion, pursuant to
the powers vested in the Company under Delaware Law.

 

10.           Duration and Scope of Agreement;
Binding Effect.  This Agreement
shall continue so long as Indemnitee shall be subject to any possible
Proceeding subject to indemnification by reason of the fact that he is or was
an Agent and shall be applicable to Proceedings commenced or continued after
execution of this Agreement, whether arising from acts or omissions occurring
before or after such execution.  This
Agreement shall be binding upon the Company and its successors and assigns
(including any direct or indirect successor by purchase, merger, consolidation
or otherwise to all or substantially all of the business or assets of the
Company) and shall inure to the benefit of Indemnitee and his spouse, assigns,
heirs, devisees, executors, administrators and other legal representatives.

 

11.           Notice by Indemnitee and Defense
of Claims.  Indemnitee agrees
promptly to notify the Company in writing upon being served with any summons,
citation, subpoena, complaint, indictment, information or other document
relating to any matter which may be subject to indemnification hereunder,  whether civil,  criminal, 
arbitrative,  administrative or
investigative;

 

7

 

but the omission so to
notify the Company will not relieve it from any liability which it may have to
Indemnitee if such omission does not actually prejudice the Company’s rights
and, if such omission does prejudice the Company’s rights, it will relieve the
Company from liability only to the extent of such prejudice; nor will such
omission relieve the Company from any liability which it may have to Indemnitee
otherwise than under this Agreement. 
With respect to any Proceeding:

 

(a)           The Company will be entitled to
participate therein at its own expense;

 

(b)           Except as otherwise provided below,
to the extent that it may wish, the Company jointly with any other indemnifying
party similarly notified will be entitled to assume the defense thereof, with
counsel reasonably satisfactory to Indemnitee. After notice from the Company to
Indemnitee of its election so to assume the defense thereof and the assumption
of such defense, the Company will not be liable to Indemnitee under this
Agreement for any attorney fees or costs subsequently incurred by Indemnitee in
connection with Indemnitee’s defense except as otherwise provided below.  Indemnitee shall have the right to employ
his counsel in such Proceeding but the fees and expenses of such counsel
incurred after notice from the Company of its assumption of the defense thereof
and the assumption of such defense shall be at the expense of Indemnitee unless
(i) the employment of counsel by Indemnitee has been authorized by the
Company, (ii) Indemnitee shall have reasonably concluded that there may be
a conflict of interest between the Company and Indemnitee in the conduct of the
defense of such action or that the Company’s counsel may not be adequately representing
Indemnitee or (iii) the Company shall not in fact have employed counsel to
assume the defense of such action, in each of which cases the fees and expenses
of counsel shall be at the expense of the Company; and

 

(c)           The Company shall not be liable to
indemnify Indemnitee under this Agreement for any amounts paid in settlement of
any action or claim effected without its written consent.  The Company shall not settle any action or
claim which would impose any limitation or penalty on Indemnitee without
Indemnitee’s written consent.  Neither
the Company nor Indemnitee will unreasonably withhold its or his consent to any
proposed settlement.

 

11.1         Contribution.  In order to provide for just and equitable
contribution in circumstances in which the indemnification provided for in this
Agreement is held by a court of competent jurisdiction to be unavailable to
Indemnitee in whole or part, the Company shall, in such an event, after taking
into account, among other things, contributions by other directors and officers
of the Company pursuant to indemnification agreements or otherwise, and, in the
absence of personal enrichment, acts of intentional fraud or dishonesty or
criminal conduct on the part of Indemnitee, contribute to the payment of
Indemnitee’s losses to the extent that, after other contributions are taken
into account, such losses exceed: 
(i) in the case of a director of the Company or any of its
subsidiaries who is not an officer of the Company or any of such subsidiaries,
the amount of fees paid to the director for serving as a director during the 12
months preceding the commencement of the Proceeding; or (ii) in the case
of a director of the Company or any of its subsidiaries who is also an officer
of the Company or any of such subsidiaries, the amount set forth in clause (i)
plus 5% of the aggregate cash compensation paid to said director for service in
such office(s) during the 12 months preceding the commencement of the
Proceeding; or (iii) in the case of an officer of the Corporation or any of
its subsidiaries, 5% of

 

8

 

the aggregate cash compensation paid to such officer for service in
such office(s) during the 12 months preceding the commencement of such
Proceeding.

 

12.           Establishment of Trust.  In order to secure the obligations of the
Company to indemnify and to advance Expenses to Indemnitee pursuant to this
Agreement, upon a Change of Control of the Company, the Company or its
successor or assign shall establish a Trust (the “Trust”) for the benefit of
the Indemnitee, the trustee (the “Trustee”) of which shall be chosen by the
Company and which is reasonably acceptable to the Indemnitee.  Thereafter, from time to time, upon receipt
of a written request from Indemnitee, the Company shall fund the Trust in
amounts sufficient to satisfy any and all Liabilities and Expenses reasonably
anticipated at the time of such request for which the Company may indemnify
Indemnitee hereunder.  The amount or
amounts to be deposited in the Trust pursuant to the foregoing funding
obligation shall be determined by mutual agreement of the Indemnitee and the
Company or, if the Company and the Indemnitee are unable to reach such an
agreement, by Independent Counsel selected jointly by the Company and the
Indemnitee.  The terms of the Trust
shall provide that except upon the consent of the Indemnitee and the Company,
(i) the Trust shall not be revoked or the principal thereof invaded,
without the written consent of the Indemnitee, (ii) the Trustee shall
advance to the Indemnitee, within 20 days of a request by the Indemnitee, any
and all Expenses, the Indemnitee hereby agreeing to reimburse the Trustee of
the Trust for all Expenses so advanced if a final determi­nation is made by a
court in a final adjudication from which there is no further right of appeal
that the Indemnitee is not entitled to be indemnified under this Agreement,
(iii) the Trust shall continue to be funded by the Company in accordance
with the funding obligations set forth in this Section, (iv) the Trustee
shall promptly pay to the Indemnitee any amounts to which the Indemnitee shall
be entitled pursuant to this Agreement, and (v) all unexpended funds in
the Trust shall revert to the Company upon a final determination by Independent
Counsel selected by Indemnitee or a court of competent jurisdiction that
Indemnitee has been fully indemnified with respect to the Proceeding giving
rise to the funding of the Trust under the terms of this Agreement.  The establishment of the Trust shall not, in
any way, diminish the Company’s obligation to indemnify Indemnitee against
Expenses and Liabilities to the full extent required by this Agreement.

 

13.           Miscellaneous Provisions.

 

13.1         Severability; Partial Indemnity.  If any provision or provisions of this
Agreement (or any portion thereof) shall be held by a court of competent juris­diction
to be invalid, illegal or unenforceable for any reason whatever:  (a) such provision shall be limited or
modified in its application to the minimum extent necessary to avoid the invalidity,
illegality or unenforceability of such provision; (b) the validity,
legality and enforceability of the remaining provisions of this Agreement shall
not in any way be affected or impaired thereby; and (c) to the fullest
extent possible, the provisions of this Agreement shall be construed so as to
give effect to the intent manifested by the provision (or portion thereof) held
invalid, illegal or unenforceable.  If
Indemnitee is entitled under any provision of this Agreement to indemnification
by the Company for some or a portion of any Expenses or Liabilities of any type
whatsoever incurred by him in the investigation, defense, settlement or appeal
of a Proceeding but not entitled to all of the total amount thereof, the
Company shall nevertheless indemnify Indemnitee for such total amount

 

9

 

except as to the portion thereof for which it has been determined
pursuant to Section 5 hereof that Indemnitee is not entitled.

 

13.2         Identical Counterparts.  This Agreement may be executed in one or
more counterparts, each of which shall for all purposes be deemed to be an
original but all of which together shall constitute one and the same
Agreement.  Only one such counterpart
signed by the party against whom enforceability is sought needs to be produced
to evidence the existence of this Agreement.

 

13.3         Interpretation of Agreement.  It is understood that the parties hereto
intend this Agreement to be interpreted and enforced so as to provide indemnifi­cation
to Indemnitee to the fullest extent not now or hereafter prohibited by law.

 

13.4         Headings.  The headings of the Sections and paragraphs
of this Agreement are inserted for convenience only and shall not be deemed to
constitute part of this Agreement or to affect the construction thereof.

 

13.5         Pronouns.  Use of the masculine pronoun shall be deemed
to include use of the feminine pronoun where appropriate.

 

13.6         Modification and Waiver.  No supplement, modification or amendment of
this Agreement shall be binding unless executed in writing by both of the
parties to this Agreement.  No waiver of
any provision of this Agreement shall be deemed to constitute a waiver of any
of the provisions hereof (whether or not similar) nor shall such waiver
constitute a continuing waiver.  No
waiver of any provision of this Agreement shall be effective unless executed in
writing.

 

13.7         Notices.  All notices, requests, demands and other
communications hereunder shall be in writing and shall be deemed to have been
duly given if (i) delivered by hand and receipted for by the party to whom
said notice or other communication shall have been directed or (ii) mailed
by certified or registered mail with postage prepaid, on the third business day
after the date on which it is so mailed:

 

(a)           If to Indemnitee, to:

 

 

Bruce Huebner

Nanogen, Inc.

10398 Pacific Center
Court

San Diego,
California  92121

Telephone:  (858)
410-4600

Telefax:       (858)
410-4949

 

10

 

(b)           If to the Company to:

 

Nanogen, Inc.

10398 Pacific Center
Court

San Diego,
California  92121

Telephone:  (858)
410-4600

Telefax:       (889)
410-4949

Attention:    Chief
Executive Officer

 

or to such other address as may have been furnished to Indemnitee by
the Company or to the Company by Indemnitee, as the case may be.

 

13.8         Governing Law.  The parties agree that this Agreement shall
be governed by, and construed and enforced in accordance with, the laws of the
State of Delaware, as applied to contracts between Delaware residents entered
into and to be performed entirely within Delaware.

 

13.9         Consent to Jurisdiction.  The Company and Indemnitee each hereby
irrevocably consent to the jurisdiction of the courts of the State of Delaware
for all purposes in connection with any action or proceeding which arises out
of or relates to this agreement and agree that any action instituted under this
agreement shall be brought only in the state courts of the State of Delaware.

 

13.10       Entire Agreement.  This Agreement represents the entire
agreement between the parties hereto, and there are no other agreements,
contracts or understanding between the parties hereto with respect to the
subject matter of this Agreement, except as specifically referred to herein or
as provided in Sections 8 and 2.1 hereof.

 

IN WITNESS WHEREOF, the
parties hereto have executed this Agreement on the day and year first above
written.

 

	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  NANOGEN, INC.

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  By:

  	
  /s/ HOWARD C. BIRNDORF

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Howard C. Birndorf

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Chief Executive Officer

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  INDEMNITEE

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  /s/ BRUCE A. HUEBNER

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Bruce A. Huebner

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  President and Chief
  Operating Officer

  

 

11

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00050-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00050-of-00352.parquet"}]]